Edwin Rock

Direttore Tecnico/Scientifico/R&S presso GLYCOMIMETICS, INC.

Patrimonio netto: 641 939 $ in data 30/04/2024

63 anni

Health Technology

Consumer Services

Profilo

Edwin P.
Rock is currently the Chief Medical Officer & Senior Vice President at GlycoMimetics, Inc. Prior to this, he worked as the Chief Medical Officer at Partner Therapeutics, Inc. Dr. Rock received his undergraduate degree from Swarthmore College and his doctorate from Stanford University School of Medicine.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
GLYCOMIMETICS, INC. 0.58%	15/03/2024	375 403 ( 0.58% )	641 939 $	30/04/2024

Posizioni attive di Edwin Rock

Società	Posizione	Inizio
GLYCOMIMETICS, INC.	Direttore Tecnico/Scientifico/R&S	06/09/2022

Tutte le posizioni attive di Edwin Rock

Precedenti posizioni note di Edwin Rock

Società	Posizione	Fine
Partner Therapeutics, Inc. Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Edwin Rock

Formazione di Edwin Rock

Swarthmore College	Undergraduate Degree
Stanford University School of Medicine	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Edwin Rock

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
GLYCOMIMETICS, INC.	Health Technology

Aziende private	1
Partner Therapeutics, Inc. Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA.	Health Technology

Vedi le connessioni aziendali